Owen Melia

Owen Melia

Auto-generated profile, based on publicly available information

Owen Melia

Section of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MPMilton Pividori
Milton Pividori
PRPadma S. Rajagopal
Padma S. Rajagopal
ABAlvaro Barbeira
Alvaro Barbeira
YLYanyu Liang
Yanyu Liang
OMOwen Melia
Owen Melia
HIHae K. Im
Hae K. Im
PhenomeXcan is a gene-based resource of gene-trait associations, providing biological contexts for translational research.

10 September 2020 in Genetic Epidemiology
Verified
Journal Article
Open access
PDF file
ABAlvaro N. Barbeira
Alvaro N. Barbeira
OMOwen J. Melia
Owen J. Melia
YLYanyu Liang
Yanyu Liang
RBRodrigo Bonazzola
Rodrigo Bonazzola
GWGao Wang
Gao Wang
HIHae K. Im
Hae K. Im
The integration of transcriptomic studies and genome‐wide association studies (GWAS) via imputed expression has seen extensive application in recent years, enabling the functional characterization and causal gene prioritization of GWAS loci. However, the techniques for imputing transcriptomic traits from DNA variation remain underdeveloped. Furthermore, associations found when linking eQTL studies to complex traits through methods like PrediXcan can lead to false positives due to linkage disequilibrium between distinct causal variants. Therefore, the best prediction performance models may not necessarily lead to more reliable causal gene discovery. With the goal of improving discoveries without increasing false positives, we develop and compare multiple transcriptomic imputation approaches using the most recent GTEx release of expression and splicing data on 17,382 RNA‐sequencing samples from 948 post‐mortem donors in 54 tissues. We find that informing prediction models with posterior causal probability from fine‐mapping (dap‐g) and borrowing information across tissues (mashr) can lead to better performance in terms of number and proportion of significant associations that are colocalized and the proportion of silver standard genes identified as indicated by precision‐recall and receiver operating characteristic curves. All prediction models are made publicly available at predictdb.org.

3 June 2021 in medRxiv
Verified
Preprint
Open access
PDF file
YLYanyu Liang
Yanyu Liang
OMOwen Melia
Owen Melia
TCTimothy J. Caroll
Timothy J. Caroll
TBThomas Brettin
Thomas Brettin
ABAndrew Brown
Andrew Brown
HIHae Kyung Im
Hae Kyung Im
Advances in brain MRI have enabled many discoveries in neuroscience. Comparison of brain MRI features between cases and controls have highlighted potential causes of psychiatric and behavioral disorders (complex traits). However, due to the cost of collecting MRI data and the difficulty in recruiting particular patient groups, most studies have small sample sizes, limiting their reliability. Furthermore, reverse causality complicates interpretation because many observed brain differences are the result rather than the cause of the disease. Here we propose a method (BrainXcan) that leverages the power of large-scale genome-wide association studies (GWAS) and reference brain MRI data to discover new mechanisms of disease etiology and validate existing ones. BrainXcan tests the association with genetic predictors of brain MRI-derived features and complex traits to pinpoint relevant region-specific and cross-brain features. As this approach requires only genetic data, BrainXcan allows us to test a host of hypotheses on mental illness, across many disorders and MRI modalities, using existing public data resources. For example, our method shows that reduced axonal density across the brain is associated with the risk of schizophrenia, consistent with the disconnectivity hypothesis. We also find structural features in the hippocampus, amygdala, and anterior cingulate cortex, among others associated with schizophrenia risk highlighting the potential of our approach, which uses orthogonal lines of evidence to inform the biology of complex traits.

6 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMilton Pividori
Milton Pividori
PRPadma S. Rajagopal
Padma S. Rajagopal
ABAlvaro N Barbeira
Alvaro N Barbeira
YLYanyu Liang
Yanyu Liang
OMOwen Melia
Owen Melia
HIHae K. Im
Hae K. Im
Large-scale genomic and transcriptomic initiatives offer unprecedented ability to study the biology of complex traits and identify target genes for precision prevention or therapy. Translation to clinical contexts, however, has been slow and challenging due to lack of biological context for identified variant-level associations. Moreover, many translational researchers lack the computational or analytic infrastructures required to fully use these resources. We integrate genome-wide association study (GWAS) summary statistics from multiple publicly available sources and data from Genotype-Tissue Expression (GTEx) v8 using PrediXcan and provide a user-friendly platform for translational researchers based on state-of-the-art algorithms. We develop a novel Bayesian colocalization method, fastENLOC, to prioritize the most likely causal gene-trait associations. Our resource, PhenomeXcan, synthesizes 8.87 million variants from GWAS on 4,091 traits with transcriptome regulation data from 49 tissues in GTEx v8 into an innovative, gene-based resource including 22,255 genes. Across the entire genome/phenome space, we find 65,603 significant associations (Bonferroni-corrected p-value of 5.5 × 10 −10 ), where 19,579 (29.8 percent) were colocalized (locus regional colocalization probability > 0.1). We successfully replicate associations from PheWAS Catalog (AUC=0.61) and OMIM (AUC=0.64). We provide examples of (a) finding novel and underreported genome-to-phenome associations, (b) exploring complex gene-trait clusters within PhenomeXcan, (c) studying phenome-to-phenome relationships between common and rare diseases via further integration of PhenomeXcan with ClinVar, and (d) evaluating potential therapeutic targets. PhenomeXcan ( phenomexcan.org ) broadens access to complex genomic and transcriptomic data and empowers translational researchers. One-Sentence Summary: PhenomeXcan is a gene-based resource of gene-trait associations with biological context that supports translational research.

3 February 2025 in Journal of Computational Physics
Verified
Journal Article
Open access
OMOwen Melia
Owen Melia
OTOlivia Tsang
Olivia Tsang
VCVasileios Charisopoulos
Vasileios Charisopoulos
YKYuehaw Khoo
Yuehaw Khoo
JHJeremy Hoskins
Jeremy Hoskins
RWRebecca Willett
Rebecca Willett

29 November 2025 in Journal of Computational Physics
Verified
Journal Article
Open access
OMOwen Melia
Owen Melia
DFDaniel Fortunato
Daniel Fortunato
JHJeremy Hoskins
Jeremy Hoskins
RWRebecca Willett
Rebecca Willett